Skip to Content
Uncategorized

Marc Andreessen: Too Many Startups Is a Good Thing

Accelerators are churning out too many startups, but it’s a good thing, Andreessen Horowitz cofounder says.
June 28, 2013

Startup accelerators like Y Combinator (see “The Startup Whisperer”) and 500 Startups are creating too many companies vying for investment dollars, and they can’t all survive, but that’s a good thing, according to Marc Andreessen, cofounder of venture capital firm Andreessen Horowitz and of the early Web browser company Netscape Communications.

Speaking Thursday at PreMoney, a San Francisco tech conference organized by 500 Startups, Andreessen said he believes one of the most positive outcomes of the rise of startup accelerators and seed funding in the technology industry is that many more people around the world are realizing it is possible to become an entrepreneur. Andreessen, who grew up in Wisconsin, said it never even occured to him to start his own company until he arrived in Silicon Valley.

The volume of young startups churned out by accelerator programs, he said, is so great that there are too many seed-stage companies, most of which won’t be able to go on to get venture funding. It’s arguable that would help him by giving him a stronger hand when negotiating deals, but Andreessen today focused on the broader benefits of many entrepreneurs starting companies. The circulation of so many ideas in an environment “like the ultimate petri dish,” he said, means even companies that don’t make it are moving the technology industry forward.

Keep Reading

Most Popular

Workers disinfect the street outside Shijiazhuang Railway Station
Workers disinfect the street outside Shijiazhuang Railway Station

Why China is still obsessed with disinfecting everything

Most public health bodies dealing with covid have long since moved on from the idea of surface transmission. China’s didn’t—and that helps it control the narrative about the disease’s origins and danger.

individual aging affects covid outcomes concept
individual aging affects covid outcomes concept

Anti-aging drugs are being tested as a way to treat covid

Drugs that rejuvenate our immune systems and make us biologically younger could help protect us from the disease’s worst effects.

Europe's AI Act concept
Europe's AI Act concept

A quick guide to the most important AI law you’ve never heard of

The European Union is planning new legislation aimed at curbing the worst harms associated with artificial intelligence.

Stay connected

Illustration by Rose WongIllustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.